SARS-CoV-2-specific mucosal immune response in vaccinated versus infected children.
Front Cell Infect Microbiol
; 14: 1231697, 2024.
Article
em En
| MEDLINE
| ID: mdl-38601739
ABSTRACT
The anti-COVID-19 intramuscular vaccination induces a strong systemic but a weak mucosal immune response in adults. Little is known about the mucosal immune response in children infected or vaccinated against SARS-CoV-2. We found that 28% of children had detectable salivary IgA against SARS-CoV-2 even before vaccination, suggesting that, in children, SARS-CoV-2 infection may be undiagnosed. After vaccination, only receptor-binding domain (RBD)-specific IgA1 significantly increased in the saliva. Conversely, infected children had significantly higher salivary RBD-IgA2 compared to IgA1, indicating that infection more than vaccination induces a specific mucosal immune response in children. Future efforts should focus on development of vaccine technologies that also activate mucosal immunity.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Imunidade nas Mucosas
/
COVID-19
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article